Shandong N.T. Pharma

Shandong NT Pharma is a pharmaceutical manufacturing subsidiary of China NT Pharma Group, based in Taian, Shandong Province. The company serves as a core production hub for the group's specialty pharmaceutical portfolio, focusing on therapeutic areas such as orthopedics, oncology, and hematology. Its flagship products include Miacalcic, a salmon calcitonin injection for bone metabolism disorders, and Libod, a doxorubicin hydrochloride liposome injection used in oncology. The company operates advanced, GMP-certified manufacturing facilities capable of producing complex formulations like liposomes and peptides. Despite financial restructuring at the parent group level, Shandong NT Pharma remains a significant player in the Chinese market for its specialized product lines.